Total Intravenous Anesthesia (TIVA) vs. Inhaled Anesthesia for Endoscopic Sinus Surgery.
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Oct 1, 2010
Trial Information
Current as of June 04, 2025
Terminated
Keywords
ClinConnect Summary
Endoscopic sinus surgery (ESS) has revolutionized the surgical treatment of chronic sinus disease, permitting outpatient sinus surgery with minimal morbidity. Previously performed using local anesthesia, the majority of patients and surgeons now prefer general anesthesia for comfort, stress containment and relative ease of accomplishing the surgical objectives1.
A critical factor in ESS is the amount of blood in the surgical field. Even for experienced endoscopists, significant bleeding may compromise the safety and completeness of the intended procedure. In addition, increased bleeding re...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of chronic rhinosinusitis
- • Indication by the surgeon of need for endoscopic sinus surgery
- Exclusion Criteria:
- • Pregnancy
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Davide Cattano, MD PhD
Principal Investigator
The University of Texas Health Science Center, Houston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials